The North American sleep-wake disorder market is estimated to grow at a CAGR of 5.9% during the forecast period. The growth of the sleep-wake disorder market in North America is attributed to the well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, the aging population of the US was around 52.3 million and Canada was around 6 million in 2018. The geriatric population is more prone to sleep-wake disorders. In addition, the presence of major market players, especially in the US including ResMed Inc., Neurocrine Biosciences, Inc., and others further supports the growth of the sleep-wake disorder market in the region during the forecast period.
The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.
To Request a Sample of our Report on Peptide and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/north-american-sleep-wake-disorder-market
Some of the players operating in the North American sleep-wake disorder market include Acorda Therapeutics Inc., Merck & Co. Inc., Pfizer Inc., Somnarus Inc., ResMed Inc., and others. In January 2018, Resmed introduced Mobi which is a portable oxygen concentrator (POC). In May 2017, Resmed launched AirTouch F20 full face mask with UltraSoft memory for comfortable therapy of the patients. In January 2017, the company received FDA approval for AirMini, one of the smallest CPAP machines.
(Get 15% Discount on Buying this Report)
A full Report of Peptide and Anticoagulant Drug Market is Available @ https://www.omrglobal.com/industry-reports/north-american-sleep-wake-disorder-market
North American Sleep-Wake Disorder Market Segmentation
By Type
- Insomnia
- Hypersomnia
- Circadian Rhythm Disorders
- Others
By Treatment
- Therapies
- Drugs
- Devices
Regional Analysis
- United States
- Canada
Company Profiles
- Aeroflow, Inc.
- Arena Pharmaceuticals, Inc.
- Acorda Therapeutics, Inc.
- Merck & Co., Inc.
- Natus Medical Inc.
- Pfizer Inc.
- ResMed Inc.
- RespireRx Pharmaceuticals Inc.
- Somnarus Inc.
- Somnetics International Inc.
- TotalCare eHealth
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
